BACKGROUND
hypoxic-ischemic  injury to the brain is a significant cause of neurological morbidity in infants.
the resultant severe and longstanding disability to infants has provided impetus for exploring aggressive therapies that give promise of injury reversal.
transplantation of stem cells has emerged as a possible modality to help improve function in damaged tissues  <cit> .
in organ-specific injury models, bone marrow cells have been shown to accumulate at the site of injury and to differentiate into tissue specific cells  <cit> .
chen and colleagues  <cit>  reported that intravenously administered marrow stromal cells accumulate in the site of ischemic brain injury, with a small percentage expressing neuronal markers.
additionally, hess et al.
<cit>  have demonstrated that, following temporary ischemia, endogenous murine bone marrow cells give rise to perivascular/mural cells, microglial cells, and a limited number of cells positive for the neuronal marker, neun.
however, it is unclear if the neun positive cells develop into mature neurons.
among the milieu of chemicals expressed in the injured microenvironment, the chemotactic chemokine, stromal cell derived factor- <dig> , has emerged as a major attractant of reparative cells.
sdf- <dig> and its receptor, cxcr <dig>  play a critical role in both engraftment of hematopoietic stem cells into bone marrow and the mobilization of stem/progenitor cells from bone marrow niches into the peripheral circulation where these cells are then available for delivery to sites of peripheral injury  <cit> .
in addition to functioning in the hematopoietic system, cxcr <dig> positive cells respond to sdf- <dig> signals in non-hematopoietic injured organs  <cit> .
that exogenous bone marrow-derived cells home to and migrate within the site of injury suggests that the brain's response to injury produces signals that attract these cells  <cit> .
functionally, sdf- <dig> is a powerful chemoattractant for cxcr4-expressing bone marrow derived cells, including putative bone marrow stem/progenitor cells such as cd34+ cells both in vitro and in vivo  <cit> .
in addition to targeting hematopoietic cells, the sdf-1/cxcr <dig> system is also known to play a critical role in embryonic brain development and adult injury repair including neurogenesis, neuroblast migration, and neuronal organization as well as endothelial progenitor cell recruitment, endothelial cell migration and vasculogenesis  <cit> .
therefore, it is important to determine the spatial and temporal expression of sdf- <dig> relative to injury; sdf- <dig> expression patterns may establish not only the location and duration of the window of opportunity for endogenous injury-mediated chemotaxis of reparative cells, but also the timeframe for therapeutic transplantation and recruitment of various stem cell populations.
recently, we showed in an adult mouse model of stroke that sdf- <dig> is expressed perivascularly in the injured region up to  <dig> days after middle cerebral artery occlusion  <cit> , suggesting that there may be a long post-injury window for homing of reparative cells.
anticipating that sdf- <dig> might be a critical factor in attracting transplanted cells to the injured area of the neonatal brain, we hypothesized that sdf- <dig> would be expressed in neonatal hypoxic-ischemic injury in a temporal and spatial pattern similar to that seen in adult models of ischemic brain injury.
RESULTS
spatial expression pattern of sdf- <dig> in uninjured brain
the sdf- <dig> antibody used for immunohistochemical localization of sdf- <dig> recognizes full length recombinant murine sdf- <dig>  and preabsorption with sdf- <dig> blocks its recognition of antigen on tissue sections .
in uninjured  neonatal mice  endogenous protein expression of sdf- <dig> in brain is limited and changes over time .
at p <dig>  the most prominent sdf- <dig> expression is within the hippocampus associated with the hippocampal fissure and the neighbouring molecular layer of the dentate gyrus, the hippocampal lacunosum molecular layer, the dentate gyrus polymorph layer, the stratum radiatum and the oriens layer.
strong expression is also associated with cells in the choroid plexus, the neurogenic subventricular zone, and large cortical neurons in the cingulate and neocortex.
additionally, large white matter tracks such as the corpus callosum and external capsule, as well as cells of the meninges, also demonstrate sdf- <dig> expression.
within the white matter tracks and the hippocampal fissure numerous blood vessels are associated with sdf- <dig> labelling .
however, unexpectedly, the granular cell layer of the dentate gyrus, ca and layer v neurocortical neurons do not show strong immunohistochemical staining for sdf- <dig> .
there is some shift in sdf- <dig> protein expression with time.
by p <dig> the hippocampal expression changes slightly .
expression associated with the hippocampal fissure is reduced while there is increased expression in hippocampal areas associated with dendritic arborization and axonal fields, including the dentate gyrus polymorph layer, the molecular layer of the dentate gyrus, the hippocampal lacunosum molecular layer and the stratum radiatum .
changes in spatial expression following hi injury
following hi injury the endogenous constitutive expression in the large neurons of the cingulate and neocortex is lost.
however, at the same time sdf- <dig> expression is dramatically up regulated in not only areas directly affected by hi, but also in the choroid plexus and by mesothelial cells of the pial meninges .
the expression of sdf- <dig> in areas of hi injury principally includes the hippocampus and striatum .
additionally, there is increased and extensive expression by cells within the hi side hemisphere white matter, particularly in the corpus callosum, external capsule and hippocampal fimbria .
interestingly, the choroid plexus and meninges expression of sdf- <dig> increases bilaterally with hi injury, although the degree of expression in the contralateral choroid plexus appears to be less robust than the hi side choroid plexus .
this suggests a generalized injury response that extends beyond the area of ischemia but potentially within the area affected by hypoxia.
temporal expression pattern of sdf- <dig> following hi injury
the first day after hi injury  patchy sdf- <dig> expression was demonstrated around blood vessels and within the parenchyma in the hippocampus and striatum within the ischemic hemisphere.
by  <dig> days after hi injury  there was robust, uniform hippocampal expression of sdf- <dig> in the ca <dig>  ca <dig>  ca <dig> and dentate regions as well as within the striatum and to a limited degree in the cingulate cortex .
by day  <dig> after the injury  sdf- <dig> continued to be expressed but was significantly reduced in the hippocampus and striatum.
however, its expression was still increased in the choroid plexus  and was associated with blood vessels in the white matter of the corpus callosum and external capsule as well as pial mesothelial cells .
by day  <dig> , sdf- <dig> expression continued to wane, and by day  <dig> post-hi injury  and beyond, expression was reduced below observable levels in the hippocampus, striatum and cortical areas.
the only expression of sdf- <dig> at these late times was found along white matter tracts of the corpus callosum and the alveus and in some sites where normal constitutive expression is observed, specifically the subventricular zone, choroid plexus and a subset of large cingulate cortex and neocortical neurons.
however, expression appeared to be depressed in hippocampal areas that normally expressed sdf- <dig>
cellular expression of sdf-1
for all time points demonstrating injury responsive sdf- <dig> expression, cellular expression was in large part localized to gfap+ reactive astrocytes .
astrocyte associated expression of sdf- <dig> is frequently found around small blood vessels, suggesting that this perivascular expression is related to astrocytic foot processes .
the lectin rca- <dig> labels cell surface carbohydrate moieties associated with both microglial and endothelial cells.
the punctate rca+/sdf-1+ labelling resembles cellular processes, however, the cell type demonstrating this co-labeling is uncertain, morphologically it does not resemble gfap+/sdf-1+ astrocytic cell processes or endothelial cell profiles .
some of the sdf-1+/rca-1+ profiles do appear to be ramified microglial cells.
however, while a subset of microglia in the hi injury area co-label with sdf- <dig> the majority do not .
further, sdf- <dig> did not co-label with markers for other process bearing cell types including oligodendrocytes .
also, as described earlier, choroid plexus and pial epithelial cells demonstrate sdf- <dig> expression .
discussion
the regulation of sdf- <dig> may be critical to the incorporation of a variety of new cells into brain.
in contrast to the prolonged up regulation of sdf- <dig> following stroke in adult mice  <cit> , its up regulation in neonatal mice after hi injury was brief.
this may reflect a difference between a mature, relatively stable, adult brain structure and a more plastic, still developing, neonatal cns where there may be a more active regulation of sdf- <dig> expression.
the timing of post-hi injury sdf- <dig> expression suggests that sdf- <dig> mediated cell homing may be most effective from  <dig> to  <dig> days after hi injury in neonatal animals, peaking around  <dig> days.
during this time sdf- <dig> expression is high around vascular elements, which may provide a portal of access for circulating reparative cells to the areas of ischemic injury.
another possible explanation for the temporal differences of sdf- <dig> expression between injured adult and neonatal brains may be related to the type of injury.
hi injury produces a more diffuse and graded tissue injury, while middle cerebral artery occlusion is more focal and discrete.
constitutive sdf- <dig> expression
interestingly, the pattern of peak expression for sdf- <dig> we show at postnatal day  <dig>   <dig> days after hi injury , is virtually identical to that recently published by felszeghy et al for i <dig> sdf-1α binding to cxcr <dig> in a rat hi model,  <dig> days after hi injury, at postnatal day  <dig>  <cit> .
in felszeghy et al's study the localization of cxcr <dig> receptors suggests the distribution of sdf- <dig> expression.
protein expression observed in our study, with sdf- <dig> antibody probes, is consistent with mrna expression patterns assayed by in situ hybridization in previous reports with some exceptions  <cit> .
the sdf- <dig> mrna expression patterns tham et al and stumm et al  <cit>  show at days p <dig> and p <dig> in rats match protein expression patterns we detected here at p <dig> and p <dig> in mice .
this includes sdf- <dig> expression in the meninges, the hippocampal fissure, choroid plexus and the proliferative subventricular zone.
sdf- <dig> mrna expression in both in situ hybridization studies  <cit>  was also associated, to a limited degree, with blood vessels, we saw the same constitutive pattern for sdf- <dig> immunostaining particularly with vessels associated with the hippocampal fissure and with white matter tracks .
in the in situ hybridization studies  <cit>  there is a decline in hippocampal fissure sdf- <dig> mrna expression between the early time points  and later time points .
a similar decrease in hippocampal fissure sdf- <dig> immunostaining was observed in our study between p <dig> and p <dig> .
of interest, in the in situ hybridization studies  <cit> , there are consistent increases in sdf- <dig> mrna in the dentate gyrus granular layers, in ca <dig>  and in layer v neocortical neurons between the early time points  and later time points .
however, we did not detect significant sdf- <dig> immunolabelling over the cell bodies of the granular cells at equivalent time points in the mice .
in contrast we did detect immunolabelling in the molecular and polymorph layers, regions of granular cell dendritic arborizations and axon fields  <cit> .
this labelling increased between p <dig> and p <dig> .
similarly we did not detect strong sdf- <dig> immunoreactivity over ca  <dig>   <dig> or  <dig> neuronal somas, but we found immunoreactivity that increased between p <dig> and p <dig> in the hippocampal lacunosum molecular layer, the stratum radiatum and the oriens layer , regions that contain the dendritic and axonal fields for the ca region  <cit> .
additionally, the layer v neocortical neurons are reported to show strong mrna labelling  <cit> , but we only detected weak diffuse antibody labelling in the area corresponding to layers v and vi in the neocortex .
the discrepancy between the reported neuronal somal labelling for mrna  <cit>  and the neuropil immunolabelling for sdf- <dig> protein we observed may be due to a lack of sensitivity of the antibody, although we can clearly detect sdf- <dig> expressing structures that are reported to express lower levels of sdf- <dig> mrna than dentate gyrus granular cells, ca and layer v neocortical neurons  <cit> .
there may also be differences in sdf- <dig> transcription and translation rates as well as message and protein turnover in different cell populations.
alternatively, this may reflect that sdf- <dig> mrna is synthesized in, and restricted to, the neuronal somas while in some neurons the protein product is mainly exported to cellular processes with little remaining in the somas.
for example, while the reported dentate gyrus granular cell mrna expression  <cit>  is more intense than any other location, including the hippocampal fissure, we show that this is at best poorly labelled immunohistochemically .
in contrast we demonstrate that regions that reflect the synaptic fields  of the granular cells  have strong immunoreactive expression for sdf- <dig>  while these same regions show little mrna expression for sdf- <dig>  <cit> .
further, structures lacking projecting processes, which could distance mrna form protein localization, like the hippocampal fissure, choroid plexus, and meninges, are reported to be strongly labelled for sdf- <dig> mrna by in situ hybridization  <cit>  and we demonstrate also by immunohistochemistry for the sdf- <dig> protein.
there is precedent for this type of pattern in neonatal hippocampus.
czarnecki et al have recently shown that synaptopodin mrna was restricted to dentate granular layer, and ca <dig>  cell somas while immunostaining for synaptopodin protein labeled dendritic layers but not the somas  <cit> .
injury induced sdf- <dig> expression
recently ceradini et al.
demonstrated that sdf- <dig> gene expression is regulated by the hypoxia responsive transcription factor hif- <dig>  <cit> .
the level of sdf- <dig> expression is directly related to the degree of hypoxia such that hypoxic gradients within tissues correlate with gradients of sdf- <dig> gene expression  <cit> .
we have previously shown in an adult middle cerebral artery occlusion model of stroke that sdf- <dig> expression follows a gradient pattern consistent with the hypoxia gradient in the penumbra  <cit> .
in our neonatal hi model the hippocampus did not appear to show a gradient of sdf- <dig> labeling during peak expression, rather the labeling was uniform and delimited by anatomical boundaries.
in contrast the striatal expression did appear to show a gradient of labeling intensity .
specific cell types may be more sensitive to hypoxic changes in inducing sdf- <dig> expression as illustrated by changes in constitutive expression of sdf- <dig> as well as induced expression in cells that did not show significant constitutive expression.
for example, subsets of neocortical neurons responded by decreasing sdf- <dig> expression in both the hypoxic and hi affected hemispheres while choroid plexus and pial labeling increased on both sides and astrocytes dramatically expressed sdf- <dig> only in the hi hemisphere.
this suggests that hif- <dig> expression may be differentially induced or that other transcription factors may be involved as well.
potential role of sdf- <dig> in injury repair
sdf- <dig> and its receptor cxcr <dig> are emerging as a common axis for directing the migration of stem cells associated with injury repair in many systems.
ji et al recently demonstrated that sdf- <dig> mediates the migration of mesenchymal stem cells to the site of injury  <cit> .
neural progenitor cells and neuroblasts express cxcr <dig> and are attracted by sdf-1α developmentally and following brain ischemia  <cit> .
recently sdf- <dig> has been shown to promote neovascularization in somatic tissues and to recruit bone marrow-derived  cells to areas of ischemic injury.
in mouse models of peripheral tissue ischemia, sdf- <dig> treated animals had increased capillary density and blood flow compared to controls and recruited injected endothelial precursor cells  to integrate into blood vessels demonstrating vasculogenesis  <cit> .
importantly this sdf- <dig> induced neovascularization has been demonstrated to improve perfusion and function in peripheral tissue ischemic injury models  <cit> .
work from our laboratory shows sdf- <dig> is up regulated in the penumbral, or peri-infarct, zone within hours of acute ischemia in adult mice.
this elevated expression persists in the peri-infarct zone for at least  <dig> days post-ischemia.
accompanying this we observe bone marrow-derived cell infiltration, pericyte and microglial engraftment and neovascularization  <cit> .
given the apparent function of sdf- <dig> to serve as an attractant for bone marrow-derived cells, including cells associated with vascular repair and vasculogenesis, as well as for other stem/progenitor cells, including neural stem cells, this brief time span of sdf- <dig> expression, peaking at  <dig> days with only limited expression through  <dig> days after the injury in neonatal animals, may be critical for the acquisition of new brain or reparative cells.
the cell type expressing sdf- <dig> and its localization is highly related to its function.
previously, we found that the principal localization of sdf- <dig> expression following injury was astrocytic, often strongly associated with small blood vessels  <cit> .
this was the first demonstration that activated, or reactive astrocytes, express sdf- <dig> in vivo following ischemia injury  <cit> .
the current study confirms and extends our original finding and demonstrates that sdf- <dig> expression is massively up regulated in reactive astrocytes in neonatal hi injury, but for a shorter period of time relative to adult middle cerebral artery occlusion ischemia.
recently imitola  <cit>  also reported sdf- <dig> expression in reactive astrocytes in an adult hi model.
earlier in vitro studies showed that cultured astrocytes up regulate sdf- <dig> expression following exposure to various cytotoxic or inflammation-inducing agents  <cit> .
additionally, we have recently shown that there is only minimal proliferation and maturation of astrocytes following hi, suggesting that the astrocytic expression of sdf- <dig> following hi originates from existing astrocytes  <cit> .
the influence of sdf- <dig> upon ischemic recovery in neonates appears to be restricted to a few days under circumstances of "normal" endogenous repair.
such a brief up regulation of sdf- <dig> in neonatal animals may disadvantage their recovery relative to adults.
however, it may still may provide a defined time frame in which therapeutically transplanted cells, or autologous stem cells mobilized from the bone marrow, may be able to home, engraft and differentiate into needed cell types.
this may also provide an opportunity to target engineered cells that express specific factors to the site of injury.
using the sdf-1/cxcr <dig> axis as a vectoral targeting system may also permit local application of cell expressed therapeutic factors in higher doses than systemic delivery would safely allow.
in adults it may be possible to use the natural up regulation of the sdf- <dig> for up to  <dig> days after the injury, while in neonates such a procedure would have to be carried out much sooner.
if transplantation protocols are carried out in humans, it may be necessary to find ways of either up regulating the sdf- <dig> or engineering the expression of the chemokine to desired temporal and spatial locals.
CONCLUSIONS
sdf- <dig> up regulation following neonatal hi injury persists only a few days in comparison to the much longer up regulation in adult models of stroke.
the up regulation in neonatal hi injury is quite prominent in astrocytes abutting small blood vessels.
this process may be critical in attracting cxcr <dig> expressing cells to the brain.
awareness of these events could be helpful in planning stem cell transplantation therapy delivered via the vascular route.

 hypoxic-ischemic injury to the brain is a significant cause of neurological morbidity in infants. the resultant severe and longstanding disability to infants has provided impetus for exploring aggressive therapies that give promise of injury reversal. transplantation of stem cells has emerged as a possible modality to help improve function in damaged tissues. in organ-specific injury models, bone marrow cells have been shown to accumulate at the site of injury and to differentiate into tissue specific cells. chen and colleagues reported that intravenously administered marrow stromal cells accumulate in the site of ischemic brain injury, with a small percentage expressing neuronal markers. additionally, hess et al. have demonstrated that, following temporary ischemia, endogenous murine bone marrow cells give rise to perivascular/mural cells, microglial cells, and a limited number of cells positive for the neuronal marker, neun. however, it is unclear if the neun positive cells develop into mature neurons. among the milieu of chemicals expressed in the injured microenvironment, the chemotactic chemokine, stromal cell derived factor-, has emerged as a major attractant of reparative cells. sdf- and its receptor, cxcr play a critical role in both engraftment of hematopoietic stem cells into bone marrow and the mobilization of stem/progenitor cells from bone marrow niches into the peripheral circulation where these cells are then available for delivery to sites of peripheral injury. in addition to functioning in the hematopoietic system, cxcr positive cells respond to sdf- signals in non-hematopoietic injured organs. that exogenous bone marrow-derived cells home to and migrate within the site of injury suggests that the brain's response to injury produces signals that attract these cells. functionally, sdf- is a powerful chemoattractant for cxcr4-expressing bone marrow derived cells, including putative bone marrow stem/progenitor cells such as cd34+ cells both in vitro and in vivo. in addition to targeting hematopoietic cells, the sdf-1/cxcr system is also known to play a critical role in embryonic brain development and adult injury repair including neurogenesis, neuroblast migration, and neuronal organization as well as endothelial progenitor cell recruitment, endothelial cell migration and vasculogenesis. therefore, it is important to determine the spatial and temporal expression of sdf- relative to injury; sdf- expression patterns may establish not only the location and duration of the window of opportunity for endogenous injury-mediated chemotaxis of reparative cells, but also the timeframe for therapeutic transplantation and recruitment of various stem cell populations. recently, we showed in an adult mouse model of stroke that sdf- is expressed perivascularly in the injured region up to days after middle cerebral artery occlusion, suggesting that there may be a long post-injury window for homing of reparative cells. anticipating that sdf- might be a critical factor in attracting transplanted cells to the injured area of the neonatal brain, we hypothesized that sdf- would be expressed in neonatal hypoxic-ischemic injury in a temporal and spatial pattern similar to that seen in adult models of ischemic brain injury.  spatial expression pattern of sdf- in uninjured brain the sdf- antibody used for immunohistochemical localization of sdf- recognizes full length recombinant murine sdf- and preabsorption with sdf- blocks its recognition of antigen on tissue sections. in uninjured neonatal mice endogenous protein expression of sdf- in brain is limited and changes over time. at p the most prominent sdf- expression is within the hippocampus associated with the hippocampal fissure and the neighbouring molecular layer of the dentate gyrus, the hippocampal lacunosum molecular layer, the dentate gyrus polymorph layer, the stratum radiatum and the oriens layer. strong expression is also associated with cells in the choroid plexus, the neurogenic subventricular zone, and large cortical neurons in the cingulate and neocortex. additionally, large white matter tracks such as the corpus callosum and external capsule, as well as cells of the meninges, also demonstrate sdf- expression. within the white matter tracks and the hippocampal fissure numerous blood vessels are associated with sdf- labelling. however, unexpectedly, the granular cell layer of the dentate gyrus, ca and layer v neurocortical neurons do not show strong immunohistochemical staining for sdf-. there is some shift in sdf- protein expression with time. by p the hippocampal expression changes slightly. expression associated with the hippocampal fissure is reduced while there is increased expression in hippocampal areas associated with dendritic arborization and axonal fields, including the dentate gyrus polymorph layer, the molecular layer of the dentate gyrus, the hippocampal lacunosum molecular layer and the stratum radiatum. changes in spatial expression following hi injury following hi injury the endogenous constitutive expression in the large neurons of the cingulate and neocortex is lost. however, at the same time sdf- expression is dramatically up regulated in not only areas directly affected by hi, but also in the choroid plexus and by mesothelial cells of the pial meninges. the expression of sdf- in areas of hi injury principally includes the hippocampus and striatum. additionally, there is increased and extensive expression by cells within the hi side hemisphere white matter, particularly in the corpus callosum, external capsule and hippocampal fimbria. interestingly, the choroid plexus and meninges expression of sdf- increases bilaterally with hi injury, although the degree of expression in the contralateral choroid plexus appears to be less robust than the hi side choroid plexus. this suggests a generalized injury response that extends beyond the area of ischemia but potentially within the area affected by hypoxia. temporal expression pattern of sdf- following hi injury the first day after hi injury patchy sdf- expression was demonstrated around blood vessels and within the parenchyma in the hippocampus and striatum within the ischemic hemisphere. by days after hi injury there was robust, uniform hippocampal expression of sdf- in the ca ca ca and dentate regions as well as within the striatum and to a limited degree in the cingulate cortex. by day after the injury sdf- continued to be expressed but was significantly reduced in the hippocampus and striatum. however, its expression was still increased in the choroid plexus and was associated with blood vessels in the white matter of the corpus callosum and external capsule as well as pial mesothelial cells. by day, sdf- expression continued to wane, and by day post-hi injury and beyond, expression was reduced below observable levels in the hippocampus, striatum and cortical areas. the only expression of sdf- at these late times was found along white matter tracts of the corpus callosum and the alveus and in some sites where normal constitutive expression is observed, specifically the subventricular zone, choroid plexus and a subset of large cingulate cortex and neocortical neurons. however, expression appeared to be depressed in hippocampal areas that normally expressed sdf- cellular expression of sdf-1 for all time points demonstrating injury responsive sdf- expression, cellular expression was in large part localized to gfap+ reactive astrocytes. astrocyte associated expression of sdf- is frequently found around small blood vessels, suggesting that this perivascular expression is related to astrocytic foot processes. the lectin rca- labels cell surface carbohydrate moieties associated with both microglial and endothelial cells. the punctate rca+/sdf-1+ labelling resembles cellular processes, however, the cell type demonstrating this co-labeling is uncertain, morphologically it does not resemble gfap+/sdf-1+ astrocytic cell processes or endothelial cell profiles. some of the sdf-1+/rca-1+ profiles do appear to be ramified microglial cells. however, while a subset of microglia in the hi injury area co-label with sdf- the majority do not. further, sdf- did not co-label with markers for other process bearing cell types including oligodendrocytes. also, as described earlier, choroid plexus and pial epithelial cells demonstrate sdf- expression. discussion the regulation of sdf- may be critical to the incorporation of a variety of new cells into brain. in contrast to the prolonged up regulation of sdf- following stroke in adult mice, its up regulation in neonatal mice after hi injury was brief. this may reflect a difference between a mature, relatively stable, adult brain structure and a more plastic, still developing, neonatal cns where there may be a more active regulation of sdf- expression. the timing of post-hi injury sdf- expression suggests that sdf- mediated cell homing may be most effective from to days after hi injury in neonatal animals, peaking around days. during this time sdf- expression is high around vascular elements, which may provide a portal of access for circulating reparative cells to the areas of ischemic injury. another possible explanation for the temporal differences of sdf- expression between injured adult and neonatal brains may be related to the type of injury. hi injury produces a more diffuse and graded tissue injury, while middle cerebral artery occlusion is more focal and discrete. constitutive sdf- expression interestingly, the pattern of peak expression for sdf- we show at postnatal day days after hi injury, is virtually identical to that recently published by felszeghy et al for i sdf-1α binding to cxcr in a rat hi model, days after hi injury, at postnatal day. in felszeghy et al's study the localization of cxcr receptors suggests the distribution of sdf- expression. protein expression observed in our study, with sdf- antibody probes, is consistent with mrna expression patterns assayed by in situ hybridization in previous reports with some exceptions. the sdf- mrna expression patterns tham et al and stumm et al show at days p and p in rats match protein expression patterns we detected here at p and p in mice. this includes sdf- expression in the meninges, the hippocampal fissure, choroid plexus and the proliferative subventricular zone. sdf- mrna expression in both in situ hybridization studies was also associated, to a limited degree, with blood vessels, we saw the same constitutive pattern for sdf- immunostaining particularly with vessels associated with the hippocampal fissure and with white matter tracks. in the in situ hybridization studies there is a decline in hippocampal fissure sdf- mrna expression between the early time points and later time points. a similar decrease in hippocampal fissure sdf- immunostaining was observed in our study between p and p. of interest, in the in situ hybridization studies, there are consistent increases in sdf- mrna in the dentate gyrus granular layers, in ca and in layer v neocortical neurons between the early time points and later time points. however, we did not detect significant sdf- immunolabelling over the cell bodies of the granular cells at equivalent time points in the mice. in contrast we did detect immunolabelling in the molecular and polymorph layers, regions of granular cell dendritic arborizations and axon fields. this labelling increased between p and p. similarly we did not detect strong sdf- immunoreactivity over ca or neuronal somas, but we found immunoreactivity that increased between p and p in the hippocampal lacunosum molecular layer, the stratum radiatum and the oriens layer, regions that contain the dendritic and axonal fields for the ca region. additionally, the layer v neocortical neurons are reported to show strong mrna labelling, but we only detected weak diffuse antibody labelling in the area corresponding to layers v and vi in the neocortex. the discrepancy between the reported neuronal somal labelling for mrna and the neuropil immunolabelling for sdf- protein we observed may be due to a lack of sensitivity of the antibody, although we can clearly detect sdf- expressing structures that are reported to express lower levels of sdf- mrna than dentate gyrus granular cells, ca and layer v neocortical neurons. there may also be differences in sdf- transcription and translation rates as well as message and protein turnover in different cell populations. alternatively, this may reflect that sdf- mrna is synthesized in, and restricted to, the neuronal somas while in some neurons the protein product is mainly exported to cellular processes with little remaining in the somas. for example, while the reported dentate gyrus granular cell mrna expression is more intense than any other location, including the hippocampal fissure, we show that this is at best poorly labelled immunohistochemically. in contrast we demonstrate that regions that reflect the synaptic fields of the granular cells have strong immunoreactive expression for sdf- while these same regions show little mrna expression for sdf-. further, structures lacking projecting processes, which could distance mrna form protein localization, like the hippocampal fissure, choroid plexus, and meninges, are reported to be strongly labelled for sdf- mrna by in situ hybridization and we demonstrate also by immunohistochemistry for the sdf- protein. there is precedent for this type of pattern in neonatal hippocampus. czarnecki et al have recently shown that synaptopodin mrna was restricted to dentate granular layer, and ca cell somas while immunostaining for synaptopodin protein labeled dendritic layers but not the somas. injury induced sdf- expression recently ceradini et al. demonstrated that sdf- gene expression is regulated by the hypoxia responsive transcription factor hif-. the level of sdf- expression is directly related to the degree of hypoxia such that hypoxic gradients within tissues correlate with gradients of sdf- gene expression. we have previously shown in an adult middle cerebral artery occlusion model of stroke that sdf- expression follows a gradient pattern consistent with the hypoxia gradient in the penumbra. in our neonatal hi model the hippocampus did not appear to show a gradient of sdf- labeling during peak expression, rather the labeling was uniform and delimited by anatomical boundaries. in contrast the striatal expression did appear to show a gradient of labeling intensity. specific cell types may be more sensitive to hypoxic changes in inducing sdf- expression as illustrated by changes in constitutive expression of sdf- as well as induced expression in cells that did not show significant constitutive expression. for example, subsets of neocortical neurons responded by decreasing sdf- expression in both the hypoxic and hi affected hemispheres while choroid plexus and pial labeling increased on both sides and astrocytes dramatically expressed sdf- only in the hi hemisphere. this suggests that hif- expression may be differentially induced or that other transcription factors may be involved as well. potential role of sdf- in injury repair sdf- and its receptor cxcr are emerging as a common axis for directing the migration of stem cells associated with injury repair in many systems. ji et al recently demonstrated that sdf- mediates the migration of mesenchymal stem cells to the site of injury. neural progenitor cells and neuroblasts express cxcr and are attracted by sdf-1α developmentally and following brain ischemia. recently sdf- has been shown to promote neovascularization in somatic tissues and to recruit bone marrow-derived cells to areas of ischemic injury. in mouse models of peripheral tissue ischemia, sdf- treated animals had increased capillary density and blood flow compared to controls and recruited injected endothelial precursor cells to integrate into blood vessels demonstrating vasculogenesis. importantly this sdf- induced neovascularization has been demonstrated to improve perfusion and function in peripheral tissue ischemic injury models. work from our laboratory shows sdf- is up regulated in the penumbral, or peri-infarct, zone within hours of acute ischemia in adult mice. this elevated expression persists in the peri-infarct zone for at least days post-ischemia. accompanying this we observe bone marrow-derived cell infiltration, pericyte and microglial engraftment and neovascularization. given the apparent function of sdf- to serve as an attractant for bone marrow-derived cells, including cells associated with vascular repair and vasculogenesis, as well as for other stem/progenitor cells, including neural stem cells, this brief time span of sdf- expression, peaking at days with only limited expression through days after the injury in neonatal animals, may be critical for the acquisition of new brain or reparative cells. the cell type expressing sdf- and its localization is highly related to its function. previously, we found that the principal localization of sdf- expression following injury was astrocytic, often strongly associated with small blood vessels. this was the first demonstration that activated, or reactive astrocytes, express sdf- in vivo following ischemia injury. the current study confirms and extends our original finding and demonstrates that sdf- expression is massively up regulated in reactive astrocytes in neonatal hi injury, but for a shorter period of time relative to adult middle cerebral artery occlusion ischemia. recently imitola also reported sdf- expression in reactive astrocytes in an adult hi model. earlier in vitro studies showed that cultured astrocytes up regulate sdf- expression following exposure to various cytotoxic or inflammation-inducing agents. additionally, we have recently shown that there is only minimal proliferation and maturation of astrocytes following hi, suggesting that the astrocytic expression of sdf- following hi originates from existing astrocytes. the influence of sdf- upon ischemic recovery in neonates appears to be restricted to a few days under circumstances of "normal" endogenous repair. such a brief up regulation of sdf- in neonatal animals may disadvantage their recovery relative to adults. however, it may still may provide a defined time frame in which therapeutically transplanted cells, or autologous stem cells mobilized from the bone marrow, may be able to home, engraft and differentiate into needed cell types. this may also provide an opportunity to target engineered cells that express specific factors to the site of injury. using the sdf-1/cxcr axis as a vectoral targeting system may also permit local application of cell expressed therapeutic factors in higher doses than systemic delivery would safely allow. in adults it may be possible to use the natural up regulation of the sdf- for up to days after the injury, while in neonates such a procedure would have to be carried out much sooner. if transplantation protocols are carried out in humans, it may be necessary to find ways of either up regulating the sdf- or engineering the expression of the chemokine to desired temporal and spatial locals.  sdf- up regulation following neonatal hi injury persists only a few days in comparison to the much longer up regulation in adult models of stroke. the up regulation in neonatal hi injury is quite prominent in astrocytes abutting small blood vessels. this process may be critical in attracting cxcr expressing cells to the brain. awareness of these events could be helpful in planning stem cell transplantation therapy delivered via the vascular route. 
therefore, without modification, following neonatal hi injury there is only a narrow period of time for endogenous sdf- mediated chemotaxis and recruitment of reparative cells, including exogenously administered stem/progenitor cells. we hypothesized that sdf- would be expressed in similar temporal and spatial patterns following hypoxic-ischemic injury in neonatal brain. sdf- expression was up regulated up to days after the injury but not at the later time points. it functions in brain embryonic development and in response to ischemic injury in helping guide neuroblast migration and vasculogenesis. the localization of sdf- along blood vessels in the hi injury zone suggests that these perivascular areas are where chemotaxic signaling for cellular recruitment originates and that reactive astrocytes are major mediators of this process. the chief sites of sdf- up regulation were astrocytes, their foot processes along blood vessels and endothelial cells.
 stromal cell-derived factor is chemotaxic for cxcr expressing bone marrow-derived cells. it functions in brain embryonic development and in response to ischemic injury in helping guide neuroblast migration and vasculogenesis. in experimental adult stroke models sdf- is expressed perivascularly in the injured region up to days after the injury, suggesting it could be a therapeutic target for tissue repair strategies. we hypothesized that sdf- would be expressed in similar temporal and spatial patterns following hypoxic-ischemic injury in neonatal brain.  twenty-five 7-day-old c57bl/j mice underwent hi injury. sdf- expression was up regulated up to days after the injury but not at the later time points. the chief sites of sdf- up regulation were astrocytes, their foot processes along blood vessels and endothelial cells.  the localization of sdf- along blood vessels in the hi injury zone suggests that these perivascular areas are where chemotaxic signaling for cellular recruitment originates and that reactive astrocytes are major mediators of this process. the associated endothelium is likely to be the site for vascular attachment and diapedesis of cxcr receptor expressing cells to enter the injured tissue. here we show that, relative to adults, neonates have a significantly smaller window of opportunity for sdf- based vascular chemotaxic recruitment of bone marrow-derived cells. therefore, without modification, following neonatal hi injury there is only a narrow period of time for endogenous sdf- mediated chemotaxis and recruitment of reparative cells, including exogenously administered stem/progenitor cells. 